Market revenue in 2021 | USD 578.0 million |
Market revenue in 2030 | USD 2,647.4 million |
Growth rate | 18.4% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.37% in 2021. Horizon Databook has segmented the North America ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the market with the largest market share in 2020. It accounted for 43.6% of global AI-based clinical trials solution providers market owing to high R&D investments, rapid technological advancements, growing adoption of technologically advanced solutions, presence of global players, and their efforts to come up with newer patents.
In addition, there are high funding and growth opportunities for startups in the region, which is expected to promote market growth. For instance, in 2020, Unlearn.AI, a U.S.-based company, received series A funding by 8VC, a leading venture capital company, in the country.
This is expected to help Unlearn in expanding its reach and increasing its product portfolio. Such instances signify growth potential of the market. In addition, industry players are making advances in their efforts to decrease timelines by adopting advanced technologies.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America ai-based clinical trials solution provider market, including forecasts for subscribers. This continent databook contains high-level insights into North America ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account